Cochlear™ Nucleus® System

The Cochlear™ Nucleus® implant system features a range of options designed to meet your hearing needs and provide you with quality hearing components.

There are two main components of the Cochlear™ Nucleus® system: an internal implant and an external sound processor.

While hearing health professionals will help match suitable implants for hearing needs, there are a variety of sound processors to suit your lifestyle and hearing preferences.

Explore your options and learn more about the convenience of Cochlear’s exclusive wireless technology.

With the most reliable implants over time,* your hearing is in good hands.

Nucleus® sound processors

Benefit from technology that can help you hear your best, connect to the people you love and experience a world of possibilities.

Nucleus® implants

Our Cochlear implants are designed to give you the best possible hearing performance for today and for the future.

Smart Bimodal hearing

Hear your best with both ears. Discover Smart Bimodal hearing from Cochlear and ReSound.

Nucleus® Implant reliability

With a cochlear implant, you want to choose the best hearing solution for today and for the future. That’s why reliability is so important.

Disclaimer

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.

In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.

In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 5 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.

For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.

For information regarding the compatibility of Cochlear's Sound Processors with Apple or Android devices visit www.cochlear.com/compatibility

Any testimonial featured on this website is intended for an Australian audience only.

* Based on comparable implant generations released by Cochlear, MED-EL and Advanced Bionics using each manufacturer’s first published CSP data at 7 and 15 years.